US equities
|
MU
$1,097.39
▲+3.03%
NVDA
$230.86
▲+1.09%
SNDK
$1,787.69
▲+2.75%
INTC
$120.00
▼-0.19%
AAPL
$330.32
▼-0.81%
GOOGL
$338.24
▼-1.70%
TSLA
$354.11
▼-0.20%
AMD
$615.73
▲+0.65%
MU
$1,097.39
▲+3.03%
NVDA
$230.86
▲+1.09%
SNDK
$1,787.69
▲+2.75%
INTC
$120.00
▼-0.19%
AAPL
$330.32
▼-0.81%
GOOGL
$338.24
▼-1.70%
TSLA
$354.11
▼-0.20%
AMD
$615.73
▲+0.65%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Articles published by Cronus Pharma LLC
Cronus Pharma Announces the Launch of Florfinasone™ Otic for the Treatment of Otitis Externa in Dogs
Today 15:02 EDT
From
Cronus Pharma LLC
Via
Business Wire
Cronus Pharma Launches First FDA-Approved Bioequivalent Robenacoxib Injection for Veterinary Use
August 26, 2026
From
Cronus Pharma LLC
Via
Business Wire
Cronus Pharma Introduces Pimobendan Chewable Tablets (First FDA-Approved Generic) for Veterinary Use
June 09, 2026
From
Cronus Pharma LLC
Via
Business Wire
Cronus Pharma Launches Butorphic® (Butorphanol Tartrate) Sterile Injectable Solution
July 21, 2025
From
Cronus Pharma LLC
Via
Business Wire
Cronus Pharma Hires Todd Brodersen as Senior Director of Sales & Marketing
December 22, 2021
From
Cronus Pharma LLC
Via
Business Wire